“If these results hold true, we may in the near future have the ability to reduce the risk of stroke by 90% in those PFO patients at greatest risk simply by evaluating this specific morphological feature of their atrial septum. Those patients theoretically could undergo a minimally invasive surgical repair of the foramen ovale and forgo a life-long dependency on blood thinning medication.’

— Robert Biederman, MD, a cardiologist at Allegheny General Hospital’s (AGH; Pittsburgh) Gerald McGinnis Cardiovascular Institute, reporting on the results of a patent foramen ovale (PFO) study at the American Heart Association meeting being held in Orlando this week, “Study findings may lead to lower stroke risk for PFO patients,” p. 4